A new drug that showed potential in laboratory tests against AIDS-causing human immunodeficiency virus has cleared another hurdle.
Researchers gave 63 HIV-infected patients, averaging 42 years of age, one or two daily injections of the drug called T-1249 for 2 weeks. One participant showed an allergic reaction and another developed a drop in the number of white blood cells called neutrophils.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.